Usana Health Sciences Shares Rise on FY25 Sales Beat Prediction, FY26 Outlook

Dow Jones

Jan 12

By Elias Schisgall

Shares of Usana Health Sciences were higher after the company projected that its 2025 sales came in ahead of expectations and guided for further growth in 2026.

Shares were up 6.6% at $21.16 in Monday morning trading. The stock has fallen 38% in the past year.

The multilevel marketer of nutritional and personal-care products said Monday that it expects to report 2025 net sales of about $925 million, ahead of its guidance for $920 million in sales.

For fiscal 2026, the company is projecting sales between $925 million and $1 billion.

It said it expects 2026 sales for its core nutritional business of $720 million to $765 million, compared with preliminary 2025 sales of about $777 million. The company said the core business would be impacted by fiscal 2026 being a 52-week year, representing one week less of sales than 2025.

Usana also projected sales from Rise Wellness of between $65 million and $80 million, a substantial increase from preliminary 2025 sales of about $16 million. Sales from Hiya are expected to grow to between $140 million to $155 million, compared with preliminary 2025 sales of about $132 million.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

January 12, 2026 10:00 ET (15:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2602494145"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2602494145\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2602494145?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2602494145","market":"nz","top_or_hot":-1,"title":"Usana Health Sciences Shares Rise on FY25 Sales Beat Prediction, FY26 Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/USNA\">Usana Health</a> Sciences were higher after the company projected that its 2025 sales came in ahead of expectations and guided for further growth in 2026. \n</p>\n<p>\n  Shares were up 6.6% at $21.16 in Monday morning trading. The stock has fallen 38% in the past year. \n</p>\n<p>\n  The multilevel marketer of nutritional and personal-care products said Monday that it expects to report 2025 net sales of about $925 million, ahead of its guidance for $920 million in sales. \n</p>\n<p>\n  For fiscal 2026, the company is projecting sales between $925 million and $1 billion. \n</p>\n<p>\n  It said it expects 2026 sales for its core nutritional business of $720 million to $765 million, compared with preliminary 2025 sales of about $777 million. The company said the core business would be impacted by fiscal 2026 being a 52-week year, representing one week less of sales than 2025. \n</p>\n<p>\n  Usana also projected sales from Rise Wellness of between $65 million and $80 million, a substantial increase from preliminary 2025 sales of about $16 million. Sales from Hiya are expected to grow to between $140 million to $155 million, compared with preliminary 2025 sales of about $132 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 10:00 ET (15:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Usana Health Sciences Shares Rise on FY25 Sales Beat Prediction, FY26 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUsana Health Sciences Shares Rise on FY25 Sales Beat Prediction, FY26 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-12 23:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of <a href=\"https://laohu8.com/S/USNA\">Usana Health</a> Sciences were higher after the company projected that its 2025 sales came in ahead of expectations and guided for further growth in 2026. \n</p>\n<p>\n  Shares were up 6.6% at $21.16 in Monday morning trading. The stock has fallen 38% in the past year. \n</p>\n<p>\n  The multilevel marketer of nutritional and personal-care products said Monday that it expects to report 2025 net sales of about $925 million, ahead of its guidance for $920 million in sales. \n</p>\n<p>\n  For fiscal 2026, the company is projecting sales between $925 million and $1 billion. \n</p>\n<p>\n  It said it expects 2026 sales for its core nutritional business of $720 million to $765 million, compared with preliminary 2025 sales of about $777 million. The company said the core business would be impacted by fiscal 2026 being a 52-week year, representing one week less of sales than 2025. \n</p>\n<p>\n  Usana also projected sales from Rise Wellness of between $65 million and $80 million, a substantial increase from preliminary 2025 sales of about $16 million. Sales from Hiya are expected to grow to between $140 million to $155 million, compared with preliminary 2025 sales of about $132 million. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 12, 2026 10:00 ET (15:00 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"优莎娜","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2602494145","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2602494145","pubTimestamp":1768230000,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Usana Health Sciences were higher after the company projected that its 2025 sales came in ahead of expectations and guided for further growth in 2026.Shares were up 6.6% at $21.16 in Monday morning trading. The stock has fallen 38% in the past year.The multilevel marketer of nutritional and personal-care products said Monday that it expects to report 2025 net sales of about $925 million, ahead of its guidance for $920 million in sales.For fiscal 2026, the company is projecting sales between $925 million and $1 billion.It said it expects 2026 sales for its core nutritional business of $720 million to $765 million, compared with preliminary 2025 sales of about $777 million. The company said the core business would be impacted by fiscal 2026 being a 52-week year, representing one week less of sales than 2025.Usana also projected sales from Rise Wellness of between $65 million and $80 million, a substantial increase from preliminary 2025 sales of about $16 million. Sales from Hiy","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"Usana Health Sciences股价因25财年销售额超出预期和26财年展望而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":1.5},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of Usana Health Sciences were higher after the company projected that its 2025 sales came in ahead of expectations and guided for further growth in 2026. \n\n\n  Shares were up 6.6% at $21.16 in Monday morning trading. The stock has fallen 38% in the past year. \n\n\n  The multilevel marketer of nutritional and personal-care products said Monday that it expects to report 2025 net sales of about $925 million, ahead of its guidance for $920 million in sales. \n\n\n  For fiscal 2026, the company is projecting sales between $925 million and $1 billion. \n\n\n  It said it expects 2026 sales for its core nutritional business of $720 million to $765 million, compared with preliminary 2025 sales of about $777 million. The company said the core business would be impacted by fiscal 2026 being a 52-week year, representing one week less of sales than 2025. \n\n\n  Usana also projected sales from Rise Wellness of between $65 million and $80 million, a substantial increase from preliminary 2025 sales of about $16 million. Sales from Hiya are expected to grow to between $140 million to $155 million, compared with preliminary 2025 sales of about $132 million. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 10:00 ET (15:00 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}